We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Open Drawer MenuClose Drawer Menu
Bioanalysis
BioTechniques
Future Drug Discovery
Future Medicinal Chemistry
Future Science OA
International Journal of Pharmacokinetics
Pharmaceutical Patent Analyst
Therapeutic Delivery
Patent Highlights

Patent highlights August–September 2022

    Published Online:4 Apr 2023https://doi.org/10.4155/ppa-2022-0049

    Abstract

    A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.

    References

    • 1. D'Amico D, Andreux PA, Valdés P, Singh A, Rinsch C, Auwerx J. Impact of the natural compound urolithin A on health, disease, and aging. Trends Mol. Med. 27(7), 687–699 (2021).
      MedlineGoogle Scholar
    • 2. Chen P, Guo Z, Chen F, Wu Y, Zhou B. Recent advances and perspectives on the health benefits of urolithin B, A bioactive natural product derived from ellagitannins. Front. Pharmacol. 13, 917266 (2022).
      Medline CASGoogle Scholar
    • 3. Rodriguez J, Pierre N, Naslain D et al. Urolithin B, a newly identified regulator of skeletal muscle mass. J. Cachexia Sarcopenia Muscle 8(4), 583–597 (2017).
      MedlineGoogle Scholar
    • 4. Luan P, D'Amico D, Andreux PA et al. Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy. Sci. Transl. Med. 13(588), eabb0319 (2021).
      Medline CASGoogle Scholar
    • 5. Thomas A, Pommier Y. Targeting topoisomerase I in the era of precision medicine. Clin. Cancer Res. 25(22), 6581–6589 (2019).
      Medline CASGoogle Scholar
    • 6. Lountos GT, Zhao XZ, Kiselev E et al. Identification of a ligand binding hot spot and structural motifs replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail screening. Nucleic Acids Res. 47(19), 10134–10150 (2019).
      Medline CASGoogle Scholar
    • 7. Zhao XZ, Wang W, Lountos GT et al. Phosphonic acid-containing inhibitors of tyrosyl-DNA phosphodiesterase 1. Front. Chem. 10, 910953 (2022).
      Medline CASGoogle Scholar
    • 8. Pearson HA, Peers C. Physiological roles for amyloid β peptides. J. Physiol. 575(1), 5–10 (2006).
      Medline CASGoogle Scholar
    • 9. Dabbagh F, Ghoshoon MB, Hemmati S, Zamani M, Mohkam M, Ghasemi Y. Engineering human urate oxidase: towards reactivating it as an important therapeutic enzyme. Curr. Pharm. Biotechnol. 17(2), 141–146 (2016).
      CASGoogle Scholar
    • 10. Izzati Mat Rani NN, Alzubaidi ZM, Azhari H, Mustapa F, Iqbal Mohd Amin MC. Novel engineering: biomimicking erythrocyte as a revolutionary platform for drugs and vaccines delivery. Eur. J. Pharmacol. 900, 174009 (2021).
      MedlineGoogle Scholar
    • 11. Costi S, Morris LS, Kirkwood KA et al. Impact of the KCNQ2/3 channel opener ezogabine on reward circuit activity and clinical symptoms in depression: results from a randomized controlled trial. Am. J. Psychiatry 178(5), 437–446 (2021).
      MedlineGoogle Scholar
    • 12. Poling A. Progressive-ratio schedules and applied behavior analysis. J. Appl. Behav. Anal. 43(2), 347–349 (2010).
      MedlineGoogle Scholar
    • 13. Ganesh RA, Venkataraman K, Sirdeshmukh R. GPR56: an adhesion GPCR involved in brain development, neurological disorders and cancer. Brain Res. 1747, 147055 (2020).
      Medline CASGoogle Scholar
    • 14. Yeung MSY, Djelloul M, Steiner E et al. Dynamics of oligodendrocyte generation in multiple sclerosis. Nature 566(7745), 538–542 (2019).
      Medline CASGoogle Scholar
    • 15. Chiou B, Gao C, Giera S et al. Cell type-specific evaluation of ADGRG1/GPR56 function in developmental central nervous system myelination. Glia 69(2), 413–423 (2021).
      Medline CASGoogle Scholar
    • 16. Kostopoulou E, Shah P. Hyperinsulinaemic hypoglycaemia – an overview of a complex clinical condition. Eur. J. Pediatr. 178(8), 1151–1160 (2019).
      MedlineGoogle Scholar
    • 17. Kailey B, van de Bunt M, Cheley S et al. SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells. Am. J. Physiol. Endocrinol. Metab. 303(9), E1107–E1116 (2012).
      Medline CASGoogle Scholar
    • 18. Miller B, Palygin O, Rufanova VA et al. p66Shc regulates renal vascular tone in hypertension-induced nephropathy. J. Clin. Invest. 126(7), 2533–2546 (2016).
      MedlineGoogle Scholar
    • 19. Benbrook DM. SHetA2 attack on mortalin and colleagues in cancer therapy and prevention. Front. Cell Dev. Biol. 10, doi:10.3389/fcell.2022.848682 (2022).
      Google Scholar
    • 20. Zhang X, Connelly J, Chao Y, Wang QJ. Multifaceted functions of protein kinase D in pathological processes and human diseases. Biomolecules 11(3), 483 (2021).
      Medline CASGoogle Scholar
    • 21. Trujillo-Viera J, El-Merahbi R, Schmidt V et al. Protein Kinase D2 drives chylomicron-mediated lipid transport in the intestine and promotes obesity. EMBO Mol. Med. 13(5), e13548 (2021).
      Medline CASGoogle Scholar
    • 22. Anzilotti C, Pratesi F, Tommasi C, Migliorini P. Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmun. Rev. 9(3), 158–160 (2010).
      Medline CASGoogle Scholar
    • 23. Christophorou MA, Castelo-Branco G, Halley-Stott RP et al. Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature 507(7490), 104–108 (2014).
      Medline CASGoogle Scholar
    • 24. Pascale RM, Simile MM, Calvisi DF, Feo CF, Feo F. S-adenosylmethionine: from the discovery of its inhibition of tumorigenesis to its use as a therapeutic agent. Cells 11(3), 409 (2022).
      Medline CASGoogle Scholar
    • 25. Kumar R, Khandelwal N, Chander Y et al. S-adenosylmethionine-dependent methyltransferase inhibitor DZNep blocks transcription and translation of SARS-CoV-2 genome with a low tendency to select for drug-resistant viral variants. Antiviral Res. 197, 105232 (2022).
      Medline CASGoogle Scholar
    • 26. Meyers C, Lisiecki J, Miller S et al. Heterotopic ossification: a comprehensive review. JBMR Plus 3(4), e10172 (2019).
      MedlineGoogle Scholar
    • 27. Nasi S, Ea H-K, Lioté F, So A, Busso N. Sodium thiosulfate prevents chondrocyte mineralization and reduces the severity of murine osteoarthritis. PLOS ONE 11(7), e0158196 (2016).
      MedlineGoogle Scholar
    • 28. Nasi S, Ehirchiou D, Bertrand J et al. The gasotransmitter hydrogen sulfide (H2S) prevents pathologic calcification (PC) in cartilage. Antioxidants 10(9), 1433 (2021).
      Medline CASGoogle Scholar
    • 29. Lanier LL. NKG2D receptor and its ligands in host defense. Cancer Immunol. Res. 3(6), 575–582 (2015).
      Medline CASGoogle Scholar
    • 30. Raulet DH, Gasser S, Gowen BG, Deng W, Jung H. Regulation of ligands for the NKG2D activating receptor. Annu. Rev. Immunol. 31(1), 413–441 (2013).
      Medline CASGoogle Scholar
    • 31. Pak DJ, Yong RJ, Kaye AD, Urman RD. Chronification of pain: mechanisms, current understanding, and clinical implications. Curr. Pain Headache Rep. 22(2), 9 (2018).
      MedlineGoogle Scholar
    • 32. Miao J, Zhou X, Ding W et al. Proliferator-activated receptor-gamma coactivator-1α haploinsufficiency promotes pain chronification after burn injury. Anesth. Analg. 130(1), 240–247 (2020).
      Medline CASGoogle Scholar